The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDMG.L Regulatory News (MDMG)

  • There is currently no data for MDMG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MDMG opens dedicated IVF Clinic at Lapino Hospital

21 Jan 2014 08:12

RNS Number : 1302Y
MD Medical Group Investments PLC
21 January 2014
 

 

MD Medical Group opens dedicated IVF Clinic at Lapino Hospital

 

21 January 2014: MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private healthcare for women and children, announces that it has opened a new in-vitro fertilisation (IVF) clinic at its Lapino Hospital.

The IVF clinic in Lapino, in the Odintsovo district of the Moscow region, is the newest addition to MDMG's unparalleled network of treatment centres in Russia. From two offices, the clinic has the capacity to oversee up to 1,000 IVF cycles per year and will offer a range of advanced IVF and gynaecology services by highly-qualified and well-respected medical personnel.

MDMG's total investment in the clinic amounted to approximately RUB 30 million. In-line with MDMG's growth strategy, the development of the IVF clinic in Lapino supplements the current network of 11 purpose built healthcare facilities providing IVF treatment, further enhancing the Company's position as the leading provider of fertility and IVF treatment in Russia. In 2013, MDMG administered a total of 5,477 IVF cycles within its network of clinics, an increase of 42% compared to 2012.

Commenting on the new opening, Elena Mladova, Chief Executive Officer of MD Medical Group, said:

"I am very pleased to be able to offer IVF treatments to patients at our Lapino Hospital. The opening of the new clinic enables MDMG to provide a full suite of fertility care to women in the Moscow region and is an important milestone in our commitment to delivering high-quality services to more patients in Russia. Having joined the company from a background in fertility treatments, I am particularly proud of the progress MDMG has made in its commitment to meet the strong and growing demand for IVF, providing increasing access to pioneering treatments to women throughout Russia."

***

For further information please contact:

EM

Moscow

Tom Blackwell / Sergii Pershyn

Tel: +7 495 363 2849

MDMG@em-comms.com 

 

Consilium Strategic Communications

London

Emma Thompson / Matthew Neal

Tel: +44 20 7920 2354

MDMG@em-comms.com 

 

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 17 modern healthcare facilities, including 2 hospitals and 15 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk and Yaroslavl. In addition, 3 franchised outpatient clinics operate in Kyiv, Ukraine.

The Company's main medical facilities are the Perinatal Medical Center (PMC), a 250-bed medical centre, which opened its doors in 2006, and Lapino hospital, a 182-bed medical centre, which opened at the end of 2012. In March 2013, the Company began construction of its third hospital in Ufa. In April 2013 MD Medical Group completed the acquisition of the IDK Medical Company, a network of women's and children's health clinics located in the Russian region of Samara ("IDK") and acquired Mother&Child clinic in Irkutsk in May 2013, which had previously operated through a franchise agreement with MD Medical Group. The same month the Company completed a large-scale modernisation project of its Mother & Child Health Clinic in Moscow. In December 2013, a new outpatient clinic was opened in Yaroslavl which became the first healthcare facility in the region to provide IVF services.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGIGDBLGDBGSB
Date   Source Headline
4th Oct 20218:00 amRNSMDMG OPENS A NEW ONCOLOGICAL CARE CENTRE
24th Sep 20214:41 pmRNSSecond Price Monitoring Extn
24th Sep 20214:35 pmRNSPrice Monitoring Extension
19th Aug 20214:40 pmRNSSecond Price Monitoring Extn
19th Aug 20214:35 pmRNSPrice Monitoring Extension
17th Aug 20219:00 amRNSEndovascular heart surgery on a newborn at MDMG
30th Jul 20214:36 pmRNSPrice Monitoring Extension
29th Jul 20218:00 amRNSMDMG REPORTS 51% GROWTH IN REVENUE IN H1 2021
1st Jul 20214:41 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
28th Jun 20218:00 amRNSFIRST OPEN-HEART SURGERY IN MDMG LAPINO HOSPITAL
29th Apr 20218:00 amRNSMDMG POSTS 40% REVENUE GROWTH IN Q1 2021
23rd Apr 20218:00 amRNSRESULTS OF THE AGM OF SHAREHOLDERS
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
22nd Mar 20213:15 pmRNSPUBLICATION OF 2020 ANNUAL REPORT
22nd Mar 20217:30 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
22nd Mar 20217:00 amRNSMDMG POSTS 30% EBITDA AND 56% NET PROFIT GROWTH
16th Mar 20217:00 amRNSMDMG TO ANNOUNCE FY 2020 IFRS FINANCIAL RESULTS
8th Feb 20217:00 amRNSMDMG POSTS 18% REVENUE GROWTH IN FY 2020
1st Feb 20217:00 amRNSMD MEDICAL GROUP ANNOUNCES THE LAUNCH OF LAPINO-4
29th Dec 20208:00 amRNSMDMG ANNOUNCES START OF CONSTRUCTION OF LAPINO-4
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
10th Nov 20205:15 pmRNSCORRECTION TO MDMG ANNOUNCEMENT
10th Nov 20201:00 pmRNSMD MEDICAL GROUP ANNOUNCEMENT
9th Nov 20208:00 amRNSMDMG ANNOUNCES START OF TRADING ON MOEX
9th Nov 20207:00 amRNSMDMG POSTS SUSTAINABLE RESULTS AND REVENUE GROWTH
5th Nov 20205:45 pmRNSMDMG ANNOUNCES LISTING ON THE MOSCOW EXCHANGE
2nd Nov 20207:10 amRNSMDMG SUBMITS APPLICATION TO MOSCOW EXCHANGE
17th Sep 202012:30 pmRNSMD MEDICAL GROUP OPENS NEW SURGERY CENTRE LAPINO-2
9th Sep 202010:00 amRNSINFORMATION ON DIVIDEND PAYMENT FOR H1 2020
7th Sep 20208:00 amRNSMDMG POSTS 2% REVENUE GROWTH, 6% EBITDA GROWTH
7th Sep 20207:30 amRNSMDMG TO ANNOUNCE H1 2020 IFRS RESULTS (CORRECTION)
4th Sep 20209:42 amRNSRESULTS OF THE EXTRAORDINARY GENERAL MEETING
1st Sep 202010:00 amRNSMDMG TO ANNOUNCE H1 2020 IFRS FINANCIAL RESULTS
12th Aug 20208:00 amRNSMDMG Announcement of Extraordinary General Meeting
31st Jul 20208:00 amRNSMDMG reports H1 2020 operational results
28th Jul 20204:41 pmRNSSecond Price Monitoring Extn
28th Jul 20204:35 pmRNSPrice Monitoring Extension
30th Apr 202012:07 pmRNSSecond Price Monitoring Extn
30th Apr 202012:02 pmRNSPrice Monitoring Extension
30th Apr 20208:00 amRNSMD Medical Group Increases Revenue by 7% in Q12020
24th Apr 20208:00 amRNSResults of the AGM of shareholders
14th Apr 20208:00 amRNSANNOUNCEMENT TO SHAREHOLDERS
26th Mar 20207:00 amRNSLAPINO STARTS TREATMENT OF PATIENTS WITH PNEUMONIA
23rd Mar 202010:10 amRNSPUBLICATION OF 2019 ANNUAL REPORT
23rd Mar 20207:15 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
23rd Mar 20207:00 amRNSMDMG POSTS 10% EBITDA GROWTH IN FY 2019
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.